HIV transmission and Kaposi's sarcoma among European women. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV transmission and Kaposi's sarcoma among European women.

AIDS. 1995 Aug;9(8):971-3. Unique Identifier : AIDSLINE MED/96014975
Serraino D; Franceschi S; Dal Maso L; La Vecchia C; Department of Epidemiology, Aviano Cancer Centre, Italy.

Abstract: OBJECTIVE: To assess the association between the presence of Kaposi's sarcoma (KS) as an AIDS-defining illness and HIV transmission categories among European women with AIDS. DESIGN: Comparison of the prevalence of KS as an AIDS-defining illness in different HIV transmission categories. METHODS: Odds ratios (OR) and 95% confidence intervals (CI) for KS were computed by means of unconditional multiple logistic regression equations. RESULTS: KS was reported in 344 (2.2%) out of 15,809 women diagnosed with AIDS. Women who reported HIV infection via heterosexual intercourse had a > twofold increase of KS risk than intravenous drug users (OR, 2.4; 95% CI, 1.9-3.0). Particularly elevated OR were observed among women originating from African or Caribbean countries (OR, 4.9; 95% CI, 3.7--6.5), and in partners of bisexual men (OR, 4.8; 95% CI, 2.8--8.2). Such risk patterns for KS were consistent in different countries, age groups and year of AIDS diagnosis. CONCLUSIONS: These results are in agreement with similar analyses from the United States, and support the existence of some putative KS agent(s) which can be acquired via sexual intercourse with bisexual men, or earlier in life in countries where non-AIDS-associated KS is frequent.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/EPIDEMIOLOGY Adult Europe Female Human HIV Infections/COMPLICATIONS/*EPIDEMIOLOGY/*TRANSMISSION Male Risk Factors Sarcoma, Kaposi's/*EPIDEMIOLOGY/ETIOLOGY Sex Behavior Sexual Partners Support, Non-U.S. Gov't JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/complications/epidemiologyadulteuropefemalehumanhivinfections/complications/KWDepidemiology/KWDtransmissionmaleriskfactorssarcoma,kaposi's/KWDepidemiology/etiologysexbehaviorsexualpartnerssupport,non-uKWDsKWDgov'tjournalarticle
960228
M9621054

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .